Monoclonal antibodies (MAbs) 32F1 and 32F3 react with two independent epitopes of a protein doublet with molecular weights of 48 and 45 kilodaltons (kD) expressed on the surface of Plasmodium falciparum (Pfs48/ 45) macrogametes and zygotes; only 32F3 blocks transmission. These MAbs were used to develop a Pfs48/45~specific competition enzyme-linked immunosorbent assay (ELISA) using 32F1 to capture antigen and labeled 32F3 for quan tification and analysis of the contribution of antibodies in human serum to transmission-blocking activity. A com parison analysis was used to determine agreement of competition ELISA titers and transmission-blocking activity as observed in the bioassay in three groups of serum samples: 37 from European travelers with previous exposure to malaria, 56 from gametocyte carriers, and 66 from schoolchildren from a malaria-endemic area in Cameroon. The index of agreement between outcomes of the ELISA and transmission-blocking assay in gametocyte carriers and in travelers was specifically defined as fair-to-moderate; in schoolchildren the agreement was not significant. The com bined analysis of all sera showed a significant and fai r-to-moderate agreement between the results of the competition ELISA and the transmission-blocking assay, with a relative specificity of 94% (of 105 cases negative in the trans mission-blocking assay, 99 were also negative in the competition ELISA) and a relative sensitivity of 44% (of 54 cases positive in the transmission-blocking assay, 24 were also positive in the competition ELISA). This study shows that a positive C48/45-ELISA is indicative for transmission-blocking activity in the mosquito assay, while a negative result does not exclude transmission-blocking activity.
Gametocytes of Plasmodium falciparum synthesize 230and 48/45-kilodalton (kD) molecules that remain exposed on the surface of macrogametes and zygotes.1" '3 Several mono clonal antibodies (MAbs) directed against these molecules block transmission of the parasite to the mosquito vector. One of the targets of transmission-blocking MAbs is the 48/ 45-kD glycoprotein doublet (Pfs48/45). Two independent, nonrepetitive epitopes of this protein react respectively with MAbs designated 32F1 and 32F3. The presence of 32F3 in a mosquito blood meal blocks transmission of the NF54 iso late of P. falciparum while 32F1 does not.4 The conventional assay measuring transmission reduction in mosquitoes using a feeder system, as described by Vermeulen and others,1 is costly, labor intensive, and thus limits the number of sera that can be tested. Development of a serologic test predicting transmission-blocking activity would greatly simplify epi demiologic studies. A positive correlation between antibody reactivity to Pfs230 and transmission-blocking activity has been found using immunoprécipitation to quantify the anti body response. Such a relation was not found for antibody reactivity to This paper describes the development of a two-site com petition enzyme-linked immunosorbent assay (ELISA) based on the 32F3 epitope. This competition ELISA was used to analyze several sets of field sera. In addition, the transmis sion-blocking activity of these field sera was determined us ing the feeder assay1 and the results obtained were compared with those of the competition ELISA using a statistical anal ysis for comparison of methods.6'7 MATERIALS AND METHODS Parasites and Pfs48/45 extract. Mature gametocytes of P. falciparum (isolate NF54) were produced in an automat ed, large-scale, culture system as described by Ponnudurai and others.8 Gametogenesis was induced by incubating the mature gametocytes in fetal calf serum (FCS) at room tem perature for 30 min. Macrogametes and zygotes were puri fied as described by Vermeulen and others.1 Pelleted para sites were stored at -70°C until use. For use in sandwich competition ELISA experiments, Pfs48/45 was extracted in 25 mM Tris-HCl, pH 8.0, containing 0.5% Nonidet P40 (NP40), 1 mM phenylmethylsulfonyl fluoride, and 1 (xg/ml each of DNase and RNase. Insoluble debris was pelleted by centrifugation (16,000 X g for 5 min at room temperature) and the soluble protein extract was stored at -70°C. The presence and quantity of Pfs48/45 in the extract was deter mined in a sandwich ELISA using labeled 32F3 and 32F1. Transmission-blocking assay. A with mem brane feeders to feed mosquitoes was used to determine transmission-blocking activity.'■ 10 Briefly, while keeping the temperature at 37°C, 14-day-old cultures containing fer tile gametocytes were mixed with prewarmed uninfected red blood cells and samples of human sera or MAbs, introduced in prewarmed feeders, and fed to Anopheles gambiae mos quitoes. All samples were tested in two experiments in the presence of complement. The minimal obtainable dilution of the sera was three-fold and the IgG preparations of blocking sera were retested using a 10-fold dilution with the malarianegative control serum. Fully engorged mosquitoes were separated and held at 26°C. Seven days later, 20 mosquitoes per feeder were dissected and the number of oocysts on the stomach wall was counted and William's mean (adjusted geometric mean) oocysts number was calculated." An ex periment was deemed to have succeeded when at least 90% of the mosquitoes examined earned oocysts in each of three controls. The adjusted geometric mean was used to deter mine the reduction activity (R) according to the equation: R 
Guideline for the interpretation of the index of agreement kappa (K )
Value blocking assay in several groups of sera. Table 2 shows the results of the competition ELISA and the transmissionblocking assay for the sera of gametocyte carriers, travelers, and schoolchildren. Using the HRPO-32F3 label, 17 (30%) of 56 of the gametocyte carriers exhibited significant com petition in the ELISA. These results were compared with the corresponding transmission-blocking activity observed in the bioassay. By shifting the transmission-blocking assay cutoff point in the gametocyte carrier group in the range of 10% to 90%, it appeared that the maximum degree of agreement between the transmission-blocking assay and the C48/45-ELISA was at the 85% reduction point. Furthermore, it ap peared that the agreement between the transmission-blocking assay and the C48/45-ELISA was not greater than chance if the cutoff point of the transmission-blocking assay was set at a reduction lower than 70% (95% confidence interval of K included the value 0). At the 85% reduction point, the index K assumed the value 0.40, indicating fair-to-moderate agreement between the outcomes o f the competition ELISA and the transmission-blocking assay ( Table 3 ). Four of the 17 positive sera from gametocyte carriers in the C48/45-ELISA test had oocyst counts that did not meet the 85% reduction standard. Of the 25 sera that were positive in the transmission-blocking assay, 13 had antibodies competing with the HRPO-32F3 MAb, indicating a relative sensitivity of 52%. Of 31 sera considered negative by the transmissionblocking assay, 27 were also found to be negative by the C48/45-ELISA, showing a relative specificity of 87% for the competition ELISA. Nine (24%) of 37 travelers exhibited significant activity in the ELISA. Nine (47%) o f 19 sera positive in the transmission-blocking assay had antibodies competing with the HRPO-32F3 MAb. All 18 sera considered negative by the transmission-blocking assay were also negative by the C48/ 45-ELISA. The index o f agreement K between the transmission-blocking assay and the C48/45-ELISA for the group of travelers assumed a value o f 0.47, indicating mod erate agreement (Table 3) . * Relative specificity = 94% (99 or 105); relative sensitivity = 44% (24 or 54); index of agreement K = 0,44.
Comparison of the transm ission-blocking assay a n d competition ELISA. The results of the com petition E L IS A were compared with those obtained by the transm issionblocking assay and analyzed by a statistical test on agree ment using a calculated index of observed agreem ent.6-7 T h e index kappa (K) was calculated from the observed and e x pected (by chance) frequencies on the diagonal o f the 2 X 2 table of transmission-blocking activity outcom es in th e

Activity in the Pfs48/45 competition enzyme-linked immunosorbent assay (C48/45-ELISA) and in the transmission-blocking (TB) as say in sera of gametocyte carriers, travelers, and schoolchildren
Comparison of activity in the transmission-blocking (TB) assay and iti the Pfs48/45 competition enzyme-linked immunosorbent assay (C48/45-ELISA) in all field sera combined*
Four (6%) of 66 sera of schoolchildren showed significant competition in the ELISA. Only 2 (20%) of 10 sera positive in the transmission-blocking assay were positive in the com petition ELISA. The relative specificity was 96% (54 of 56). The index of agreement K between the results of the C48/ 45-ELISA and the transmission-blocking assay was low with a wide confidence interval (K = 0.22, 95% confidence in terval = -0.23, 0.67). Since the confidence interval contains zero, chance can explain the observed level of agreement.
A summary of the data of the three groups combined is given in Table 4 . The index of agreement K between the results of the C48/45-ELISA and the transmission-blocking assay was K = 0.44; with a 95% confidence interval of 0.28, 0.60, indicating fair-to-moderate agreement ( Table 1 ). The ELISA outcomes show a relative specificity of 94% (99 of 105) and a relative sensitivity of 44% (24 o f 54).
DISCUSSION
An MAb-based competition ELISA was developed to study the natural antibody reactivity to Pfs48/45 in field sera in comparison with transmission-blocking activity as ob served in a bioassay. The 32F3-labeled MAb was used in this competition ELISA because of its blocking activity in the transmission-blocking assay. Competition of antibodies in field sera with labeled 32F3 for binding to Pfs48/45 might therefore be relevant for transmission-blocking activity. Transmission blockade has not been found in serum of rab bits immunized with recombinant Pfs48/45 (Roeffen W and others, unpublished data). Therefore, Pfs48/45 extract from parasites was used as antigen in the competition ELISA.
The concentration of unlabeled antibody necessary to re duce binding of the labeled MAb in the competition ELISA was lower for HRPO-labeled 32F3 than for biotin-labeled 32F3. This was supported by the observation that in the competition ELISA with HRPO-32F3 as label, nine of 19 blocking field sera were positive in contrast to seven o f 19 when biotin-32F3 was used. Therefore, HRPO-labeled 32F3 Transmission-blocking activity was found in a high pro portion o f sera from gametocyte carriers and travelers to malarious regions. In the group o f travelers, all sera positive in the C48/45-ELISA blocked transmission, but 10 o f 19 blockers were negative in the C48/45-ELISA. The Pfs48/45 epitope has several, surface-exposed domains recognized by M Abs.1617 Since only one domain potentially involved in blocking activity could be analyzed in this study, reactivity to other domains might explain why 10 o f 19 blockers were negative in the C48/45-ELISA. Since sera from people living in endemic areas react to all epitopes tested on the Pfs230, several alternative explanations may be considered. It may be that blocking reactivity is targeted to molecules other than that of Pfs48/45, or that blocking does not only depend on IK antibody, but may also be caused by nonspecific factors as observed in P. vivax and P. falciparum infections. 19 In our analyses, it appeared, however, that IgG fractions o f sera with transmission-blocking activity also blocked transmis sion. Although this does not exclude the presence o f non specific transmission-blocking activity, specific activity can explain the results. It is also possible that the C48/45-ELISA is less sensitive than the transmission-blocking assay.
Comparison of activity by index of agreement K in the Pfs48/45 competition enzyme-linked immunosorbent assay (C48/45-ELISA) and the transmission-blocking assay in sera of gametocyte carriers, travelers, and schoolchildren
The results for the gametocyte carriers and schoolchildren were also problematic because four o f 17 and two of four sera positive in the C48/45-ELISA, respectively, were in the nonblocking group (< 85%). It should be noted that the cat egory R < 85% in the transmission-blocking assay does not necessarily mean that there is no transmission reduction.
It only shows that repeated experiments with sera from this group exhibited considerable variation o f the transmissionréduction value, making it impossible to subdivide the group with R values < 85% in different subclasses.
A statistical test for comparison o f proportions or asso ciation is not considered appropriate for the comparison o f the outcomes o f the transmission-blocking assay and the C48/45-ELISA. Besides sensitivity and specificity, measure ment o f agreement rather than association is required. The kappa (K) measure, which measures the amount of agree ment beyond chance, seems to (it our purpose. In two of three groups of sera, agreement was significant, (fair-to-mod erate for gametocyte carriers and travelers) and only in the group of schoolchildren could agreement between the out comes of the two methods be explained by chance. Never theless, overall a fair-to-moderate agreement was found. In , the C48/45-ELISA exh ib ited reasonable lev els o f sen sitivity (S: 44%) and sp ecificity ( s In a Papua New Guinea study, an MAb (MAb IIC5B10) specifically reacting with an epitope o f Pfs48/45 was used to compete with a panel of field sera in a Pfs48/45 compe tition ELISA. The results of this competition ELISA did not correlate with either the capacity o f these field sera to pre cipitate Pfs48/45 from a radiolabeled gametocyte extract or the transmission-blocking activity observed in these same field sera. 20 On the other hand, the analyses o f the Papua New Guinea sera revealed a correlation between serologic reactivity to Pfs230, but not to Pfs48/45, and transmission-blocking ac tivity.5 Our competition ELISA is specific (94%), but only positive in 44% o f the sera with transmission-blocking ac tivity. This leaves the possibility that the competition ELISA is insensitive or that the transmission-blocking activity in these sera is directed to other sexual stage molecules, e.g., Pfs230 as observed by Graves and others. 5 In summary, the transmission-blocking bioassay is a cost ly, comparatively labor-intensive, and time-consuming test. A Pfs48/45 epitope-specific competition ELISA has a sig nificant predictive value to the transmission-blocking activ ity, which is limited by the fact that only 44% o f all trans mission-blocking sera are positive in the competition ELISA. This indicates the need to increase the sensitivity o f the test and/or to define additional transmission-blocking targets.
